PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7871033-4	1993	This profile of activity was unlike that of haloperidol, which acutely caused a nonselective increase in the number of active A9 and A10 DA cells, associated with the ability of this agent to cause DI of both A9 and A10 DA cells after repeated treatment.	Haloperidol	44-55	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	133-136	
7871033-4	1993	This profile of activity was unlike that of haloperidol, which acutely caused a nonselective increase in the number of active A9 and A10 DA cells, associated with the ability of this agent to cause DI of both A9 and A10 DA cells after repeated treatment.	Haloperidol	44-55	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	216-219	
1283534-0	1992	U-50,488H into A10 reduces haloperidol-induced elevations of accumbens dopamine.	Haloperidol	27-38	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	15-18	
3607497-0	1987	Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.	Haloperidol	44-55	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	94-97	
3607497-2	1987	clozapine (CLOZ) and haloperidol (HAL) on the activity of dopamine (DA) neurons of the ventral tegmental area (VTA or A10) and the substantia nigra pars compacta (SNC or A9).	Haloperidol	21-32	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	111-121	
3607497-2	1987	clozapine (CLOZ) and haloperidol (HAL) on the activity of dopamine (DA) neurons of the ventral tegmental area (VTA or A10) and the substantia nigra pars compacta (SNC or A9).	Haloperidol	34-37	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	111-121	
3607497-11	1987	This hemi-transection also left intact the activation of A10 neurons produced by HAL and CLOZ, but it did prevent the excitatory action of HAL on most A9 neurons sampled.	Haloperidol	81-84	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	57-60	
3607497-16	1987	It is suggested that the different pharmacological and clinical properties of HAL and CLOZ may be partially explained by a differential mode of action on the A10 and A9 subpopulations of DA cells.	Haloperidol	78-81	immunoglobulin kappa variable 6D-21 (non-functional)	Homo sapiens	158-161